EX-23.1 3 tm2123236d2_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the use of our report dated March 23, 2021, with respect to the consolidated financial statements of Entasis Therapeutics Holdings Inc. incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.

 

/s/ KPMG LLP

 

Boston, Massachusetts

 

August 2, 2021